ACON Infectious Mononucleosis Rapid Tests Receive CLIA Waiver
go back to news archivesThe U.S. FDA have granted a CLIA Waiver for the Whole Blood procedure of ACON Labs Infectious Mononucleosis Rapid Tests, available in both strip and device formats. The CLIA Waiver for the Whole Blood procedure indicates that the tests are simple enough to be used by non-laboratory trained personnel in more than 100,000 physician offices and laboratories in the USA.
The tests give results in just 5 minutes. Clinical studies demonstrated positive agreement of 97%, negative agreement of greater than 99%, and overall agreement of 99% for all specimen types combined versus a leading slide agglutination method.
Infectious Mononucleosis is caused by the Epstein-Barr virus (EBV), one of the most common human viruses. Early and rapid detection is an important first step toward treatment and avoidance of potentially serious complications
Source : ACON Laboratories, Inc. View Company Information
Posted on October 10, 2005
LATEST MICROBIOLOGY NEWS
-
AOAC Validated iQ-Check Vibrio PCR Kit
01 Apr 2025 -
AI-Powered Precision For Colony Counting
27 Mar 2025
MICROBIOLOGY EVENTS
-
Mycotoxin Detection and Analysis: Strategies to Support Your Testing Program
3 Apr 2025 -
15th Conference of The World Mycotoxin Forum® – WMFmeetsSalzburg
7 Apr 2025 -
ESCMID European Congress of Clinical Microbiology and Infectious Diseases
11 Apr 2025 -
IBQC 2025
14 Apr 2025 -
IFU Technical Workshop 2025
15 Apr 2025 -
Validation of Water Systems for Microbial Control
23 Apr 2025 -
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
Free Expert Webinar: Advancing Drinking Water Microbiology Testing Compliance & Efficiency
29 Apr 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025